Changes in atrium and thoracic aorta reactivity to adenosinergic and adrenergic agonists in experimental hyperhomocysteinemia

Journal of Cardiovascular Pharmacology

Volumn 47, Issue 5, 2006, Pages 673-679

  Tasatargil, Arda ^a   Sadan, Gulay ^a   Karasu, Edibe ^a   Ozdem, Sebahat ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Adenosine; Adrenergic agonists; Hyperhomocysteinemia; Rat right atria; Rat thoracic aorta

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; ISOPRENALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; FEMORAL ARTERY; HEART ATRIUM; HEART RATE; HEART RIGHT ATRIUM; HYPERHOMOCYSTEINEMIA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; THORACIC AORTA;

ADENOSINE; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; DIPYRIDAMOLE; HEART ATRIA; HEART RATE; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; ISOPROTERENOL; MALE; METHIONINE; PHENYLEPHRINE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; THEOPHYLLINE; VASOCONSTRICTION; VASODILATION;

EID: 33748185601     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000211756.31820.17     Document Type: Article

References (36)

1. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem. 1990;1:228-237.
2. Deussen A. Adenosine-the missing link to understanding homocysteine pathogenicity or more smoke on the horizon?. Cardiovasc Res. 2003;59:259-261.
3. Schutz W, Schrader J, Gerlach E. Different sites of adenosine formation in the heart. Am J Physiol. 1981;240:H963-H970.
4. Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol Rev. 1990;70:761-845.
5. Fredholm BB, IJzerman AP, Jacobson KA, et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 2001;53:527-552.
6. Mubagwa K, Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res. 2001;52:25-39.
7. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
8. Durante W, Sunahara FA, Sen AK. Alterations in atrial reactivity in a strain of spontaneously diabetic rats. Br J Pharmacol. 1989;97:1137-1144.
9. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis. 1989;32:73-97.
10. Dobson JG Jr, Ordway RW, Fenton RA. Endogenous adenosine inhibits catecholamine contractile responses in normoxic hearts. Am J Physiol. 1986;251:H455-H462.
11. Endoh M, Yamashita S. Adenosine antagonizes the positive inotropic action mediated via beta-, but not alpha-adrenoceptors in the rabbit papillary muscle. Eur J Pharmacol. 1980;65:445-448.
12. Schrader J, Baumann G, Gerlach E. Adenosine as inhibitor of myocardial effects of catecholamines. Pflugers Arch. 1977;372:29-35.
13. Linden J. Structure and function of A1 adenosine receptors. FASEB J. 1991;5:2668-2676.
14. Wilbur SL, Marchlinski FE. Adenosine as an antiarrhythmic agent. Am J Cardiol. 1997;79:30-37.
15. Smits P, Lenders JW, Willemsen JJ, et al. Adenosine attenuates the response to sympathetic stimuli in humans. Hypertension. 1991;18:216-223.
16. Rongen GA, Lenders JW, Lambrou J, et al. Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine. Hypertension. 1996;27:933-938.
17. Riksen NP, Rongen GA, Blom HJ, et al. Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia. Cardiovasc Res. 2003;59:271-276.
18. Chen YF, Li PL, Zou AP. Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function. Circulation. 2002;106:1275-1281.
19. Riksen NP, Rongen GA, Boers GH, et al. Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol. 2005;25:109-114.
20. Newman WH, Lee JT Jr, Webb JG. Persistent desensitization of the heart to the inotropic action of isoproterenol by adenosine. Res Commun Chem Pathol Pharmacol. 1989;66:233-254.
21. Lentz SR, Sobey CG, Piegors DJ, et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest. 1996;98:24-29.
22. Ungvari Z, Pacher P, Rischak K, et al. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol. 1999;19:1899-1904.
23. Medina MA, Amores-Sanchez MI. Homocysteine: an emergent cardiovascular risk factor?. Eur J Clin Invest. 2000;30:754-762.
24. Shryock JC, Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol. 1997;79:2-10.
25. Green RM, Stiles GL. Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex. J Clin Invest. 1986;77:222-227.
26. Wu SN, Linden J, Visentin S, et al. Enhanced sensitivity of heart cells to adenosine and up-regulation of receptor number after treatment of guinea pigs with theophylline. Circ Res. 1989;65:1066-1077.
27. Varani K, Portaluppi F, Gessi S, et al. Dose and time effects of caffeine intake on human platelet adenosine A (2A) receptors: functional and biochemical aspects. Circulation. 2000;102:285-289.
28. Raymond JR. Multiple mechanisms of receptor-G protein signaling specificity. Am J Physiol. 1995;269:F141-F158.
29. Freissmuth M, Schutz W, Linder ME. Interactions of the bovine brain A1-adenosine receptor with recombinant G protein alpha-subunits. Selectivity for rGi alpha-3. J Biol Chem. 1991;266:17778-17783.
30. Abebe W, Mustafa SJ. A1 adenosine receptor-mediated Ins(1,4,5)P3 generation in allergic rabbit airway smooth muscle. Am J Physiol. 1998;275:L990-L997.
31. Marala RB, Mustafa SJ. Direct evidence for the coupling of A2-adenosine receptor to stimulatory guanine nucleotide-binding-protein in bovine brain striatum. J Pharmacol Exp Ther. 1993;266:294-300.
32. Stefanovic V, Vlahovic P, Savic V, et al. Adenosine stimulates 5′-nucleotidase activity in rat mesangial cells via A2 receptors. FEBS Lett. 1993;331:96-100.
33. Ferguson SS, Barak LS, Zhang J, et al. G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can J Physiol Pharmacol. 1996;74:1095-1110.
34. Minneman KP. Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+. Pharmacol Rev. 1988;40:87-119.
35. Liebau S, Hohlfeld J, Forstermann U. The inhibition of alpha 1-adrenoceptor-mediated contractions of rabbit pulmonary artery by Ca2+-withdrawal, pertussis toxin and N-ethylmaleimide is dependent on agonist intrinsic efficacy. Naunyn-Schmiedeberg's Arch Pharmacol. 1989;339:496-502.
36. Xu J, Gao F, Ma XL, et al. Effect of aging on the negative chronotropic and anti-beta-adrenergic actions of adenosine in the rat heart. J Cardiovasc Pharmacol. 1999;34:904-912.